Press

Press kit & media bio.

Resources for journalists, producers, and conference organizers covering prostate cancer, BPH, and image-guided urology.

Download headshot Download CV (PDF)

Media contact

(212) 434-6580

arastine@northwell.edu

Name & pronunciation

Art Rastinehad, D.O., pronounced RAH-stin-eh-hahd. Full name: Ardeshir Rustom Rastinehad, D.O.

Short bio (50 words)

Art Rastinehad, D.O. is a board-certified urologist and fellowship-trained interventional radiologist. He serves as System Director of Prostate Cancer and Vice Chairman of Lenox Hill Urology at Northwell Health in New York City.

Long bio

Art Rastinehad, D.O. is the first urologist in the United States to be dual fellowship-trained in Urologic Oncology and Interventional Radiology, completing both fellowships at the National Cancer Institute (NIH). He is System Director of Prostate Cancer and Vice Chairman of Lenox Hill Urology at Northwell Health.

Dr. Rastinehad helped develop and validate MRI/ultrasound fusion-guided prostate biopsy, now the standard of care for prostate cancer detection. He performed the first MR/US fusion-guided, electromagnetically tracked transperineal prostate biopsy and the first-in-human gold-nanoshell directed photothermal ablation of prostate cancer.

He has authored more than 75 peer-reviewed publications and multiple textbook chapters, including chapters in Campbell-Walsh-Wein Urology (11th and 12th editions). He is the senior editor of Interventional Urology (Springer, 2016), the first comprehensive textbook on the subspecialty. He was named the AUA Young Urologist of the Year in 2019.

His clinical practice focuses on minimally invasive, image-guided treatment of prostate cancer (focal therapy, cryotherapy, clinical trials), enlarged prostate (prostate artery embolization), varicoceles, and renal masses.

Topics for comment

MRI-fusion prostate biopsy
Focal therapy for prostate cancer
Prostate artery embolization (PAE)
Gold-nanoshell directed ablation
PSA screening guidelines
Active surveillance
Renal embolization & angiomyolipoma

Affiliations

System Director of Prostate Cancer. Northwell Health
Vice Chairman, Lenox Hill Urology. Northwell Health
American Urological Association
Society of Interventional Radiology

Selected publications

PubMed-indexed work

Curated first- and senior-author papers for citation and background. Each entry links to the PubMed record.

Full PubMed record

Sort by year

See full research & publications

Press kit & media bio.

Name & pronunciation

Short bio (50 words)

Long bio

Topics for comment

Affiliations

PubMed-indexed work

Glue (n-Butyl Cyanoacrylate) for Prostate Artery Embolization: Development of a Glue Penetration Score and Association with Clinical Outcomes

Novel MRI-US fusion with advanced annotation in focal cryoablation for prostate cancer: medium-term outcomes and learning curve insights

A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation

A Detailed Clinical Case of Localized Prostate Tumors Treated with Nanoparticle-Assisted Sub-Ablative Laser Ablation

Narrative review — focal therapy: are we ready to change the prostate cancer treatment paradigm?

Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies

TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate Cancer

Novel Automated 3D Surgical Planning Tool and MRI/Ultrasound Fusion Technology for Nanoparticle Ablation and Cryoablation of the Prostate

Adjunctive Coil Embolization of the Prostatic Arteries After Particle Embolization for Prostatic Artery Embolization

MRI Fusion Transperineal Prostate Biopsy: Instructions and Troubleshooting

Transperineal vs Transrectal Targeted Biopsy With Electromagnetically-Tracked MR/US Fusion Guidance for the Detection of Clinically Significant Prostate Cancer

Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy

A Cohort of Transperineal Electromagnetically-Tracked MRI/Ultrasonography Fusion-Guided Biopsy: Assessing the Impact of Inter-Reader Variability on Cancer Detection

Gold Nanoshell-Localized Photothermal Ablation of Prostate Tumors in a Clinical Pilot Device Study

Endovascular Therapy for Vasculogenic Erectile Dysfunction: A Systematic Review and Meta-Analysis of Arterial and Venous Therapies

Implementation of Multiparametric MRI Technology for Evaluation of Patients With Suspicion for Prostate Cancer in the Clinical Practice Setting

Advances in Prostate Cancer Imaging

Targeted Ablative Therapies for Prostate Cancer

Risk Stratification of Prostate Cancer Using Apparent Diffusion Coefficient Value and Lesion Volume on Multiparametric MRI

Reproducibility of Multiparametric MRI and Fusion-Guided Prostate Biopsy: Multi-Institutional External Validation

Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR/US Fusion-Guided Prostate Biopsies

In Patients With a Previous Negative Prostate Biopsy and a Suspicious MRI Lesion, Is a 12-Core Biopsy Still Necessary in Addition to a Targeted Biopsy?

Multiparametric MRI Outperforms the Prostate Cancer Prevention Trial Risk Calculator in Predicting Clinically Significant Prostate Cancer

Improving Detection of Clinically Significant Prostate Cancer: MRI/Transrectal Ultrasound Fusion-Guided Prostate Biopsy

Selective Arterial Prostatic Embolization (SAPE) for Refractory Hematuria of Prostatic Origin